Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
PDAC 2024: The World’s Premier Mineral Exploration & Mining Convention
-
Kura Oncology to Participate in Three Upcoming Investor Conferences
-
AppTech’s Strategic Partner InstaCash on Track to Launch Cutting Edge Peer-to-Peer Mobile Payments Platform Q2 2024: User Sign-Ups Available Now
-
Blink Charging to Host Fourth Quarter and Year End 2023 Conference Call on Thursday, March 14, 2024
-
InflaRx Appoints Jan Medina as Head of Investor Relations
-
DeFi Technologies Inc. Announces Record AUM of C$590 Million, Launch of Valour Inc.’s Ripple (XRP) and Binance (BNB) ETPs
-
Bitech Technologies Appoints Sid Sung as Its New Chief Innovation Officer to Lead the Digital Revolution in the Renewable Energy Industry
-
Agrify Corporation Announces First Multi-Year and Two-Million Dollar Extraction Managed Services Contract with Customer in Michigan
-
Venus Concept Announces CE Mark for Venus Versa Pro in Europe
-
Harmony Biosciences Reports Fourth Quarter and Full Year 2023 Financial Results and Business Updates
-
MGP Ingredients Reports Strong Fourth Quarter and Full Year 2023 Results
-
Verrica Pharmaceuticals to Provide a Corporate Update and Report Fourth Quarter and Full-Year 2023 Financial Results on February 29, 2024
-
BridgeBio Pharma Reports Fourth Quarter and Full Year 2023 Financial Results and Business Update
-
Laureate Education Reports Financial Results for the Fourth Quarter and Full-Year 2023 and Provides 2024 Outlook
-
PDAC 2024: The World’s Premier Mineral Exploration & Mining Convention
-
Hillman Reports Fourth Quarter 2023 Results; Provides 2024 Guidance
-
AGF Investments Announces February 2024 Cash Distributions for AGF Enhanced U.S. Equity Income Fund and AGF Systematic Global Infrastructure ETF
-
Allied Announces Renewal of Normal Course Issuer Bid
-
MGP Ingredients Declares $0.12 Quarterly Dividend
-
Rail Vision to Showcase its Safety AI-Driven Systems to US Railroad Leaders
-
Netcompany - Transactions in connection with share buyback programme
-
Drug insurance: A single-payer pharmacare program would jeopardize coverage quality for 21 million Canadians
-
Colliers recognized among best professional services firms by IAOP
-
Form 8.3 - [ LXi REIT PLC - 21 02 2024] - (CGWL)
-
EnviroGold Global Appoints Mr. Kyle Appleby as CFO
-
Osisko Development Intercepts 610 g/t Gold Over 0.46 Meters in Underground Drilling at Trixie, Tintic Project
-
The Joint Corp. to Host Conference Call on Thursday, March 7th to Discuss Fourth Quarter and Year-end 2023 Results
-
Helium Evolution Provides Operations Update
-
Brady Corporation Reports Fiscal 2024 Second Quarter Results and Raises the low end of its Fiscal 2024 Guidance
-
Evergold – Magnetic Survey Over DEM1 Porphyry Prospect, B.C., Reveals New Mirror-Image DEM2 Target to the Southeast
-
Cielo Announces Private Placement of Convertible Debenture Units for up to $5.0 Million to Advance Renewable Fuel Projects, Confirms Final Credit Facility Draw and Magazine Feature
-
Pool Corporation Reports Year End and Fourth Quarter 2023 Results; Provides 2024 Earnings Guidance
-
Supremex Announces Q4 and Year-End 2023 Results and Increases Dividend
-
Morphic Announces Corporate Highlights and Financial Results for the Full Year 2023
-
Parsons Announces Pricing Of $700.0 Million Of Convertible Senior Notes Due 2029; Enters into Concurrent Capped Call Transactions to Offset Potential Dilution
-
Rhythm Pharmaceuticals Announces Clinical Development Plan of Setmelanotide for Hypothalamic Obesity in Japan
-
BigCommerce Announces Fourth Quarter and Fiscal Year 2023 Financial Results
-
Agios to Present at the TD Cowen 44th Annual Health Care Conference on March 4, 2024
-
Ventyx Biosciences to Present Results of the Phase 2 Trial of VTX002 in Ulcerative Colitis at the 19th Congress of the European Crohn's and Colitis Organisation (ECCO)
-
NeuroMetrix Reports Q4 and Full Year 2023 Business Highlights
-
Chicago Atlantic Real Estate Finance Schedules Fourth Quarter 2023 Earnings Release and Conference Call Date
-
Chimerix to Report Fourth Quarter and Year End 2023 Financial Results and Provide an Operational Update on February 29, 2024
-
C3is Inc. Granted 180-Day Extension by Nasdaq to Regain Compliance With Minimum Bid Price Rule
-
ProMIS Neurosciences to Present at the 2024 BIO CEO & Investor Conference
-
Cosmin Pitigoi to Join Flywire as Chief Financial Officer
-
Kymera Therapeutics Announces Fourth Quarter and Full Year 2023 Financial Results and Provides a Business Update
-
Rhythm Pharmaceuticals Reports Fourth Quarter 2023 Financial Results and Business Update
-
Autolus Therapeutics announces publication in Nature Communications
-
Aduro Clean Technologies Announces Upcoming Conference Schedule and Engagement of Outside The Box Capital to Provide Marketing and Investor Relations Services
-
Monopar Announces Promising Preclinical Data for its MNPR-101 Radiopharma Program Targeting Advanced Cancers

